It is too soon to start betting on a US recession, former US Federal Reserve chairman Alan Greenspan said, citing one of his preferred gauges of US business spending.
While market-based signals and economist projections have shown rising odds that the expansion might stumble, Greenspan said history shows the economy is not sinking into a contraction.
That was Greenspan’s conclusion based on a measure of how much companies are borrowing as they make decisions on investing in the coming months.
The ratio shows that on an aggregate basis, companies have not really resumed borrowing since the financial crisis.
“The economy has been weakening, but we’re still in a period of deleveraging,” Greenspan said in an interview.
His office reaffirmed his outlook on Wednesday: “No recession in the last half century, at least, began from a period of deleveraging.”
His conclusion is based on looking at capital investment on a six-month lag as a proxy for when companies decided to make the appropriations, then dividing that by cash flow.
The approach shows that the amount of cash corporate boards choose to invest in long-term assets has been a “significant leading indicator” of capital spending, he said.
Specifically, Greenspan pulls the underlying data from the Fed’s quarterly Financial Accounts of the US, a thick statistical publication also known as the Z.1 in the central bank’s nomenclature of reports.
The capital expenditure data were found in the section on nonfinancial corporate business, specifically capital expenditures minus changes in inventories divided by gross savings.
That ratio has not been greater than one since the end of 2007. The last recession started in December that year.
“I’m cautious about the long-term outlook, and we’re currently running under a 2 percent real GDP annual growth rate, but we nonetheless don’t appear to be sinking into recession, despite the fact that economic growth has slowed significantly,” Greenspan said.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained